Crinetics Pharmaceuticals Inc (STU:6Z4) Transcripts
Q3 2024 Crinetics Pharmaceuticals Inc Earnings Call Transcript
Nov 12, 2024
€55
(-2.65%)
Earnings
Q2 2024 Crinetics Pharmaceuticals Inc Earnings Call Transcript
Aug 08, 2024
€43.6
(-0.91%)
Earnings
Q4 2023 Crinetics Pharmaceuticals Inc Earnings Call Transcript
Feb 28, 2024
€41.6
(+16.85%)
Earnings
Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Crinetics Pharmaceuticals Inc Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome Transcript
Dec 18, 2023
Crinetics Pharmaceuticals Inc Data Review Conference Call Transcript
Sep 11, 2023
Crinetics Pharmaceuticals Inc to Host Key Opinion Leader (KOL) Webinar Transcript
Aug 08, 2023
Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Crinetics Pharmaceuticals Inc to Discuss CRN04894 Phase 1 Multiple-Ascending Dose Data Call Transcript
May 25, 2022
Crinetics Pharmaceuticals Inc To Discuss Results From MAD Cohorts Of The Phase 1 Trial Of CRN04777 Corporate Call Transcript
Mar 30, 2022
Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Crinetics Pharmaceuticals Inc CRN04777 Phase 1 Program Results Call Transcript
Sep 15, 2021
Crinetics Pharmaceuticals Inc Review CRN04894 Single Ascending Dose Results Call Transcript
Aug 10, 2021
Q4 2020 Crinetics Pharmaceuticals Inc Earnings Call Transcript
Mar 30, 2021
€12.5
(-6.02%)
Earnings
Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Crinetics Pharmaceuticals, Inc. - Special Call Transcript
Nov 20, 2020
Crinetics Pharmaceuticals Inc Review Of Phase 2 Paltusotine Results Call Transcript
Oct 26, 2020
Crinetics Pharmaceuticals, Inc. - Special Call Transcript
Apr 07, 2020
Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Jan 15, 2020